Sikander Nazish, Ahmad Tanveer, Mazcuri Misauq, Ali Nadir, Thapaliya Pratikshya, Nasreen Shagufta, Abid Ambreen
Thoracic Surgery, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Cureus. 2021 Jan 8;13(1):e12583. doi: 10.7759/cureus.12583.
Chronic tuberculous empyema (CTE) is a common complication of tuberculosis that requires some form of surgical intervention along with anti-tuberculosis therapy (ATT). The aim of this study was to determine the optimum duration of pre-operative ATT in CTE prior to the decortication and its outcomes.
This comparative prospective study was conducted from August 2019 to August 2020 in the Department of Thoracic Surgery, Jinnah Postgraduate Medical Centre, Karachi, Pakistan. A total of 70 patients were included in the study. They were grouped into two arms: patients operated at or within six weeks of ATT commencement (Group A) and patients operated after six weeks of ATT (Group B). Both groups had 35 participants each. Patients were evaluated based on a self-administered questionnaire. A p-value of less than 0.05 was considered significant.
In this study, there were 55 (78.6%) males and 15 (21.4%) females with a mean age of 33.5 ± 11.2 years. Diagnosis of CTE was most commonly made through sputum acid-fast bacilli (AFB) smear (n=35, 50%) which most commonly involved right upper (n=20, 28.6%) and lower lung lobes (n=20, 28.6%). Complications such as air leaks, need for ventilator support, need for intensive care unit (ICU) stay, residual collection, and pneumothorax all were significantly higher in Group A (31 patients out of 35) compared to Group B (18 patients out of 35). In Group B, 21 (60%) participants had full post-operative expansion of lungs, compared to eight (22.8%) in Group A (p=0.002). In total five participants had failure to expand lungs; all of them belonged to Group A (p=0.02).
The optimum timing of surgery and preoperative ATT is crucial for achieving better outcomes and requires good collaboration between the treating pulmonologist and thoracic surgeon. Our study highlights the importance of pre-operative ATT for at least more than six weeks before undertaking decortication for better outcomes and minimizing morbidity.
慢性结核性脓胸(CTE)是结核病的常见并发症,除抗结核治疗(ATT)外,还需要某种形式的手术干预。本研究的目的是确定在进行胸膜剥脱术之前,CTE患者术前ATT的最佳持续时间及其结果。
本比较性前瞻性研究于2019年8月至2020年8月在巴基斯坦卡拉奇真纳研究生医学中心胸外科进行。共有70名患者纳入研究。他们被分为两组:在ATT开始时或开始后六周内接受手术的患者(A组)和在ATT开始六周后接受手术的患者(B组)。两组各有35名参与者。根据一份自填问卷对患者进行评估。p值小于0.05被认为具有统计学意义。
本研究中,有55名(78.6%)男性和15名(21.4%)女性,平均年龄为33.5±11.2岁。CTE的诊断最常见于痰涂片抗酸杆菌(AFB)检查(n = 35,50%),最常累及右上叶(n = 20,28.6%)和下叶(n = 20,28.6%)。A组(35名患者中的31名)的漏气、需要呼吸机支持、需要入住重症监护病房(ICU)、残余积液和气胸等并发症显著高于B组(35名患者中的18名)。在B组中,21名(60%)参与者术后肺完全复张,而A组为8名(22.8%)(p = 0.002)。共有5名参与者肺未复张;他们均属于A组(p = 0.02)。
手术和术前ATT的最佳时机对于取得更好的结果至关重要,需要治疗肺病专家和胸外科医生之间的良好协作。我们的研究强调了在进行胸膜剥脱术之前至少进行六周以上术前ATT对于获得更好结果和降低发病率的重要性。